Author:
Liu Long,Qi Lu,Lei Chunpu,Wang Yu,Zhang Wei,Liu Ying,Li Pu,Bai Haihong,Li Yan,Li Yinjuan,Liu Ju,Xie Liangzhi,Wang Xinghe
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference16 articles.
1. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution;Kuek;Postgrad. Med. J.,2007
2. Tumor necrosis factor-α signaling in macrophages;Parameswaran;Crit. Rev. Eukaryot. Gene Expr.,2010
3. Humira label, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125057s415lbl.pdf/ (Accessed 11 March 2020), U.S. Food and Drug Administration.
4. A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab;Kaur;Ann. Rheum. Dis.,2017
5. Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients;Bultman;Aliment. Pharmacol. Ther.,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献